Methods for detecting or predicting the risk of fatty liver disease, diagnostic agent kits and biomarkers for detecting fatty liver disease, methods for determining the progress of liver fibrosis in the subject, and the progress of liver fibrosis in the subject. Biomarker for determination

摘要

An object of the present invention is to provide a new diagnostic method for fatty liver disease that can be carried out more easily and does not impose a burden on patients and medical staff. Any of the long-chain acylcarnitines selected from the group consisting of octadecenoylcarnitine, tetradecenoylcarnitine, tetradecanoylcarnitine, hexadecanoylcarnitine, octadecanoylcarnitine, and octadecadienoylcarnitine in body fluid samples. The problem can be solved by measuring one or more amounts and comparing them with the reference value.